IL-6 also activates the Janus kinase (JAK) signal transducer and activator of the STAT3 (signal transducer and activator of transcription 3) pathway, leading to adverse effects in tumours, such as reduced apoptosis in HCC cells (Huang et al., 2015; Jung et al., 2015). Here, IL6 is linked to hepatocellular carcinoma.